Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

Similar articles for PubMed (Select 23762720)

1.

Glossopharyngeal Dystonia Secondary to a Lurasidone-Fluoxetine CYP-3A4 Interaction.

Paul S, Cooke BK, Nguyen M.

Case Rep Psychiatry. 2013;2013:136194. doi: 10.1155/2013/136194. Epub 2013 May 16.

2.

Severe laryngeal dystonia in a patient receiving zuclopenthixol "Acuphase" and fluoxetine.

Hood S, Orr K, Bennett L, Davies S.

Australas Psychiatry. 2010 Apr;18(2):174-6. doi: 10.3109/10398560903473686.

PMID:
20175668
3.

Pisa syndrome and laryngeal dystonia induced by novel antipsychotics.

Miodownik C, Lerner V, Witztum E.

Isr J Psychiatry Relat Sci. 2011;48(3):195-200.

4.

Antipsychotic drug-induced acute laryngeal dystonia: two case reports and a mini review.

Christodoulou C, Kalaitzi C.

J Psychopharmacol. 2005 May;19(3):307-11. Review.

PMID:
15888517
5.

Clinical potential of lurasidone in the management of schizophrenia.

Samalin L, Garnier M, Llorca PM.

Ther Clin Risk Manag. 2011;7:239-50. doi: 10.2147/TCRM.S12701. Epub 2011 Jun 27.

6.

Bupropion-induced acute dystonia.

Detweiler MB, Harpold GJ.

Ann Pharmacother. 2002 Feb;36(2):251-4.

PMID:
11847943
7.

Ziprasidone-induced tardive laryngeal dystonia: a case report.

Tsai CS, Lee Y, Chang YY, Lin PY.

Gen Hosp Psychiatry. 2008 May-Jun;30(3):277-9. doi: 10.1016/j.genhosppsych.2007.08.012.

PMID:
18433661
8.

Lurasidone for schizophrenia: a review of the efficacy and safety profile for this newly approved second-generation antipsychotic.

Citrome L.

Int J Clin Pract. 2011 Feb;65(2):189-210. doi: 10.1111/j.1742-1241.2010.02587.x. Epub 2010 Dec 3. Review.

PMID:
21129135
9.

An acute dystonic reaction with long-term use of ranitidine in an intensive care unit patient.

Wilson LB, Woodward AM, Ferrara JJ.

J La State Med Soc. 1997 Jan;149(1):36-8.

PMID:
9033194
10.

Iloperidone, asenapine, and lurasidone: a brief overview of 3 new second-generation antipsychotics.

Citrome L.

Postgrad Med. 2011 Mar;123(2):153-62. doi: 10.3810/pgm.2011.03.2273. Review.

PMID:
21474903
11.

Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence.

Sproule BA, Naranjo CA, Brenmer KE, Hassan PC.

Clin Pharmacokinet. 1997 Dec;33(6):454-71. Review.

PMID:
9435993
12.

Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update.

Spina E, Santoro V, D'Arrigo C.

Clin Ther. 2008 Jul;30(7):1206-27. Review.

PMID:
18691982
13.

Cocaine-associated dystonic reaction.

Fines RE, Brady WJ, DeBehnke DJ.

Am J Emerg Med. 1997 Sep;15(5):513-5.

PMID:
9270394
14.

Characteristics of dystonic movements in primary and symptomatic dystonias.

Svetel M, Ivanović N, Marinković J, Jović J, Dragasević N, Kostić VS.

J Neurol Neurosurg Psychiatry. 2004 Feb;75(2):329-30.

15.

Metabolic drug interactions with newer antipsychotics: a comparative review.

Spina E, de Leon J.

Basic Clin Pharmacol Toxicol. 2007 Jan;100(1):4-22. Review.

PMID:
17214606
16.

Ranitidine-induced acute dystonia.

Kapur V, Barber KR, Peddireddy R.

Am J Emerg Med. 1999 May;17(3):258-60.

PMID:
10337885
17.

Acute paroxysmal dystonia induced by fluoxetine.

Domínguez-Morán JA, Callejo JM, Fernández-Ruiz LC, Martínez-Castrillo JC.

Mov Disord. 2001 Jul;16(4):767-9.

PMID:
11481710
18.

Acute dystonia after initial doses of ziprasidone: a case report.

Yumru M, Savas HA, Selek S, Savas E.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Jun;30(4):745-7. Epub 2006 Mar 6.

PMID:
16580766
19.

Characteristics and risk factors of acute dystonia in schizophrenic patients treated with nemonapride, a selective dopamine antagonist.

Kondo T, Otani K, Tokinaga N, Ishida M, Yasui N, Kaneko S.

J Clin Psychopharmacol. 1999 Feb;19(1):45-50.

PMID:
9934942
20.

Albendazole-induced dystonic reaction: a case report.

Incecik F, Hergüner MO, Ozcan K, Altunbaşak S.

Turk J Pediatr. 2011 Nov-Dec;53(6):709-10.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk